|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61P 7/06 | |||
| C12N 9/22 |
| (11) | Number of the document | 3122880 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15715937.7 |
| Date of filing the European patent application | 2015-03-26 | |
| (97) | Date of publication of the European application | 2017-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/022856 |
| Date | 2015-03-26 |
| (87) | Number | WO 2015/148863 |
| Date | 2015-10-01 |
| (30) | Number | Date | Country code |
| 201461970588 P | 2014-03-26 | US | |
| 201462084487 P | 2014-11-25 | US |
| (72) |
FRIEDLAND, Ari, E., US
MAEDER, Morgan, L., US
WELSTEAD, G., Grant, US
BUMCROT, David, A., US
COTTA-RAMUSINO, Cecilia, US
|
| (73) |
Editas Medicine, Inc.,
11 Hurley Street, Cambridge, MA 02141,
US
|
| (54) | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE |
| CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE |